[Economic control in anesthesia and intensive care medicine--do we need new muscle relaxants? Pro]

Anasthesiol Intensivmed Notfallmed Schmerzther. 1996 Feb;31(1):44-5.
[Article in German]
No abstract available

MeSH terms

  • Anesthesia, General / economics*
  • Cost Control / trends
  • Cost-Benefit Analysis / trends
  • Critical Care / economics*
  • Drug Costs / trends*
  • Germany
  • Humans
  • Neuromuscular Nondepolarizing Agents / economics*

Substances

  • Neuromuscular Nondepolarizing Agents